SHARE
COPY LINK

EBOLA

France to bring in Ebola checks ‘on all transport’

French president François Hollande said on Friday that measures to counter the risk of Ebola reaching France will be increased with tests to be carried out on people arriving in France on “all forms of transport”, meaning boats as well as planes.

France to bring in Ebola checks 'on all transport'
A passenger arriving at Charles de Gaulle airport is checked for Ebola. Photo: Kenzo Tribouillard/AFP

France is already carrying out checks at airports on passengers arriving from those countries in West Africa hit by the Ebola epidemic, but Hollande said on Friday those checks will also be introduced on “all modes of transport” to counter the risk of the disease.

“France must have control systems in place that should not simply apply to air traffic, but all modes of transport, including maritime. This is what we will put in place,” Hollande said at a press conference at the EU summit in Brussels.

France's health minister later clarified that the checks would involve taking the temperature of passengers arriving in France by boat from West Africa. 

These boats "will be checked, which means that people who will get off, sailors or passengers, will have their temperature taken," said the minister Marisol Touraine.

Hollande also called for people not to “catastrophize" around the growing Ebola epidemic, nor fall into "inaction".

“Catastrophizing will only produce panic,” he said. “Ebola needs to be treated in Africa and around the world,” he said.

France is yet to report its first case of Ebola but in recent weeks there have been several false alarms, notably when a nurse, who treated an Ebola patient fell ill in Paris.

She was admitted to hospital and isolated in a special ward, but tests later revealed she did not have the disease, that has claimed nearly 5,000 victims, mostly in Liberia, Sierra Leone and Guinea.

France's Institute of public health surveillance (InVS) said there has been a total of 480 suspected cases of Ebola reported in France since June.

However only 17 of those were serious enough to be classed as “possible cases”.

None of those turned out to be positive, but with a case being confirmed in New York on Friday, many see it as only a matter of time before France confirms its first victim of Ebola.

Scientists in the UK predicted it would happen before the end of October.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

EBOLA

Spanish researchers develop five-strain vaccine against lethal Ebola virus

Spanish researchers are working on a vaccine against all five strains of the killer Ebola virus in what would be a world first, Madrid's October 12 Hospital said Wednesday (July 11).

Spanish researchers develop five-strain vaccine against lethal Ebola virus
Ebola protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time. Photo: AFP

A prototype vaccine developed by pharmaceutical group Merck is already in use, but acts only against the most virulent, “Zaire” strain.

Despite not having market approval, Merck's rVSV-ZEBOV was administered to people in the Democratic Republic of Congo in May, with UN approval, in a bid to contain an outbreak of the same virus that killed more than 11,300 in three West African countries from 2013 to 2015, sparking international panic.

For several months, a team from the October 12 Hospital has been working with researchers at two other hospitals in the capital to examine and learn from blood samples taken from three people cured of Ebola in Spain.

Lead researcher Rafael Delgado told reporters the difficulty lay in the fact that the virus protects itself with proteins that act as a shield, and only exposes its vulnerable zones for short periods of time.

That makes it tough for the body's immune system to fight the virus.

The three Spanish patients had produced “very effective” viral antibodies, though in a “small quantity” and only against the Zaire strain they were contaminated with.

Delgado, head of microbiology at the hospital, said researchers are aiming to reproduce these antibodies on a larger scale, and in a way that would make them efficient against all five virus strains.

US medical giant Johnson & Johnson is separately developing an experimental vaccine against two Ebola strains.

Delgado said researchers hope to get results from mouse experiments within a year.

The Ebola epidemic caused alarm in Spain in 2014 when a nursing assistant, Teresa Romero, became the first person infected outside Africa.

She caught the disease while tending to a Spanish missionary repatriated from Sierra Leone, who died in Spain in September that year.